Back to Journals » Journal of Inflammation Research » Volume 15
Wang N, Gu Y, Li L, et al. J Inflamm Res. 2022;15:3477–3499.
The authors advised that due to an error that inadvertently occurred at the time of figure assembly, the scratch test result of si-SDC1 MBA-MD-231 cells was erroneously placed in the position of the scratch assay results of the si-SORBS1 MCF-7 cells and therefore the 8F part of the figure is incorrect.
The correct Figure 8 is shown below.
|
Picture 8 The effects of SORBS1 knockdown or overexpression on BC cell invasion and migration. (A) Quantitative PCR analysis of SORBS1 expression levels in si-SORBS1 control, if-SORBS1oe-SORBS1 control and oe-SORBS1 breast cancer cell lines (MCF-7 and MDA-MB-231). (B) Western blot of SORBS1 expression levels in si-SORBS1 control, if-SORBS1oe-SORBS1 control and oe-SORBS1 breast cancer cell lines (MCF-7 and MDA-MB-231). (VS) The effects of SORBS1 knockdown or overexpressed upon invasion of MDA-MB-231 breast cancer cells. (D) The effects of SORBS1 knockdown or overexpressed upon invasion of MCF-7 breast cancer cells. (E) The effects of SORBS1 knockdown or overexpressed upon migration of MDA-MB-231 breast cancer cells shown by scratch assays. (F) The effects of SORBS1 knockdown or overexpressed during migration of MCF-7 breast cancer cells shown by scratch assays. **P P |
The authors apologize for this error and inform that it does not affect the results and conclusions of the article.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution-NonCommercial License (unported, v3.0). By accessing the work, you hereby agree to the Terms. Non-commercial uses of the work are permitted without further permission from Dove Medical Press Limited, provided the work is properly attributed. To obtain permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
